Yasmin Plus FC tablets.
PDF Leaflet Revision Date: 12 May 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Oral contraception and improvement in folate status.
Dosage (summary)
One tablet daily for 28 days, starting on day 1 of the menstrual cycle.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not indicated during pregnancy or breastfeeding.
Key Drug Interactions
- Enzyme inducers (e.g., phenytoin, rifampicin)
- CYP3A4 inhibitors (e.g., ketoconazole)
Contraindications
- Hypersensitivity
- Thromboembolic events
- Severe hepatic disease
- Severe renal insufficiency
- Pregnancy
Common side effects
- Nausea
- Breast pain
- Emotional lability
Counselling Points
- Take at the same time daily
- Use barrier method if pills are missed
- Not a protection against STDs
Serious warnings
- Increased risk of thromboembolic events
- Monitor for migraine exacerbation
Important Disclaimer
The Yasmin Plus FC tablets. professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
